Clinicians

One Psychedelic Dose Is Now a Phase III Argument

Can Belgium Turn Routine GP Data Into Cardiovascular Prevention?

Cancer Screening Is Still Designed for the Able-Bodied Patient

MOGAD Is Close to Its First Real Treatment

A New Global Heart Attack Definition Targets a Diagnostic Blind Spot in Women

GLP-1s Are Winning on Weight. Muscle Is Becoming the Next Clinical Question

Breast Cancer Just Proved Why Biomarker Selection Matters

Menstrual Migraine Was Never Just Regular Migraine

Brain Cancer Finally Gets the PET Scan It Has Been Missing
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
